tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Catanzaro, 298 are a BUY (78.84%), 80 are a HOLD (21.16%).
Analyst Joseph Catanzaro, currently employed at MIZUHO, carries an average stock price target met ratio of 47.45% that have a potential upside of 36.2% achieved within 166 days. Previously, Joseph Catanzaro worked at PIPER SANDLER.
Joseph Catanzaro’s has documented 751 price targets and ratings displayed on 54 stocks. The coverage is on Healthcare, Consumer Cyclical, Industrials, Consumer Defensive sectors.
Most recent stock forecast was given on APGE, Apogee Therapeutics, Common Stock at 24-Jun-2026.
Analyst best performing recommendations are on CTMX (CYTOMX THERAPEUTICS).
The best stock recommendation documented was for CTMX (CYTOMX THERAPEUTICS) at 4/14/2025. The price target of $2.5 was fulfilled within 29 days with a profit of $1.89 (309.84%) receiving and performance score of 106.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Sep-2021
$1.75
$-0.27 (-13.37%)
1 years 10 months 12 days ago
(27-Aug-2024)
1/4 (25%)
$0.07 (4.17%)
2
Buy Since 12-Jan-2022
$1.5
$-0.52 (-25.74%)
1 years 10 months 18 days ago
(21-Aug-2024)
0/2 (0%)
$-0.05 (-3.23%)
Hold Since 14-May-2024
1 years 10 months 18 days ago
(21-Aug-2024)
0/4 (0%)
$31.56 (191.97%)
Buy Since 30-Aug-2021
$48
$45.98 (2276.24%)
$49
4 years 2 months 28 days ago
(11-Apr-2022)
0/3 (0%)
$31.56 (191.97%)
Buy Since 30-Aug-2021
$48
$45.98 (2276.24%)
$49
4 years 2 months 28 days ago
(11-Apr-2022)
1/4 (25%)
$31.56 (191.97%)
117
Which stock is Joseph Catanzaro is most bullish on?
Which stock is Joseph Catanzaro is most reserved on?
What Year was the first public recommendation made by Joseph Catanzaro?
